Latest long-term debt for VERO: $6.3M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for VERO is $6.3M as of September 2025. That compares with $32M in the prior-year period — down 80.4% year over year. Investors often review this figure alongside Venus Concept's historical trend and sector peers before judging valuation or financial health.
Over the past year, VERO's long-term debt moved from $32M to $6.3M — a 80.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Venus Concept's operating scale or balance-sheet position.
A long-term debt figure of $6.3M for VERO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting VERO's long-term debt ($6.3M), review year-over-year change from $32M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Venus Concept's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.